Clinical Trials Browser

Phase 1/2 × Adenocarcinoma of Lung × nintedanib × Clear all

NCT03361319 2020-11-24

N3

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Recurrence